Tandem Diabetes Gets $21.3M

San Diego-based Tandem Diabetes, a developer of insulin pumps, has raised $21.3M out of a $52.3M funding round, according to a regulatory filing by the firm Friday. Details on the funding have not been released by the company. Tandem has previously raised funding from such firms as Domain Associates, Second Technology Capital Investors, and TPG Ventures. More information »